Should treatment of low-level rifampicin mono-resistant tuberculosis be different?

Armand Van Deun, Tom Decroo

Research output: Contribution to journalEditorial

Original languageEnglish
Article number100240
JournalJournal of Clinical Tuberculosis and Other Mycobacterial Diseases
Volume23
Number of pages2
ISSN2405-5794
DOIs
Publication statusPublished - 2021

Keywords

  • Rifampicin-resistant tuberculosis
  • Disputed mutations
  • Diagnosis
  • Xpert MTB/RIF
  • Treatment regimen
  • Treatment outcome

Cite this